Laboratory Corp Of America Holdings

Research Laboratory Corp Of America Holdings (LH) on Bullrun: valuation model: 6.0% undervalued, market cap USD 22.93B, P/E 24.8, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Laboratory Corp Of America Holdings as 6.0% undervalued; latest market cap is USD 22.93B; P/E is 24.8; dividend yield is 1.0%.

About Laboratory Corp Of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.

Frequently asked questions

Is Laboratory Corp Of America Holdings overvalued or undervalued?

Bullrun's valuation model currently marks Laboratory Corp Of America Holdings as 6.0% undervalued.

What is Laboratory Corp Of America Holdings's market cap?

Laboratory Corp Of America Holdings's market capitalization is USD 22.93B.

What is Laboratory Corp Of America Holdings's P/E ratio?

Laboratory Corp Of America Holdings's price-to-earnings (P/E) ratio is 24.8.

Does Laboratory Corp Of America Holdings pay a dividend?

Laboratory Corp Of America Holdings has a dividend yield of 1.0%.

What does Laboratory Corp Of America Holdings do?

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.